Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2005 1
2006 1
2008 1
2012 2
2013 8
2014 19
2015 9
2016 11
2017 8
2018 8
2019 14
2020 12
2021 23
2022 30
2023 31
2024 12

Text availability

Article attribute

Article type

Publication date

Search Results

180 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for xinxiang tao
Search for Xingtian Tao instead (1 results)
Traditional Chinese Medicine Compound (Tongxinluo) and Clinical Outcomes of Patients With Acute Myocardial Infarction: The CTS-AMI Randomized Clinical Trial.
Yang Y, Li X, Chen G, Xian Y, Zhang H, Wu Y, Yang Y, Wu J, Wang C, He S, Wang Z, Wang Y, Wang Z, Liu H, Wang X, Zhang M, Zhang J, Li J, An T, Guan H, Li L, Shang M, Yao C, Han Y, Zhang B, Gao R, Peterson ED; CTS-AMI Investigators. Yang Y, et al. JAMA. 2023 Oct 24;330(16):1534-1545. doi: 10.1001/jama.2023.19524. JAMA. 2023. PMID: 37874574 Clinical Trial.
Neoantigen: A New Breakthrough in Tumor Immunotherapy.
Zhang Z, Lu M, Qin Y, Gao W, Tao L, Su W, Zhong J. Zhang Z, et al. Front Immunol. 2021 Apr 16;12:672356. doi: 10.3389/fimmu.2021.672356. eCollection 2021. Front Immunol. 2021. PMID: 33936118 Free PMC article. Review.
Sintilimab versus placebo in combination with chemotherapy as first line treatment for locally advanced or metastatic oesophageal squamous cell carcinoma (ORIENT-15): multicentre, randomised, double blind, phase 3 trial.
Lu Z, Wang J, Shu Y, Liu L, Kong L, Yang L, Wang B, Sun G, Ji Y, Cao G, Liu H, Cui T, Li N, Qiu W, Li G, Hou X, Luo H, Xue L, Zhang Y, Yue W, Liu Z, Wang X, Gao S, Pan Y, Galais MP, Zaanan A, Ma Z, Li H, Wang Y, Shen L; ORIENT-15 study group. Lu Z, et al. BMJ. 2022 Apr 19;377:e068714. doi: 10.1136/bmj-2021-068714. BMJ. 2022. PMID: 35440464 Free PMC article. Clinical Trial.
Dynamic networks of P300-related process.
Tao Q, Jiang L, Li F, Qiu Y, Yi C, Si Y, Li C, Zhang T, Yao D, Xu P. Tao Q, et al. Cogn Neurodyn. 2022 Oct;16(5):975-985. doi: 10.1007/s11571-021-09753-3. Epub 2022 Jan 10. Cogn Neurodyn. 2022. PMID: 36237399 Free PMC article.
USP10 as a Potential Therapeutic Target in Human Cancers.
Tao L, Liu X, Jiang X, Zhang K, Wang Y, Li X, Jiang S, Han T. Tao L, et al. Genes (Basel). 2022 May 6;13(5):831. doi: 10.3390/genes13050831. Genes (Basel). 2022. PMID: 35627217 Free PMC article. Review.
Genomic analysis of a recombinant coxsackievirus A19 identified in Xinxiang, China, in 2019.
Yi L, Zhang L, Feng L, Luan X, Zhao Q, Xu P, Wang Y, Tao L, Wu W. Yi L, et al. Arch Virol. 2022 Jun;167(6):1405-1420. doi: 10.1007/s00705-022-05433-7. Epub 2022 Apr 10. Arch Virol. 2022. PMID: 35397685
In this study, we determined the complete genome sequence of a CV-A19 isolate identified in a stool sample from a child with hand, foot, and mouth disease in Xinxiang, Henan, China, in 2019 and named it CV-A19 strain 2019103106/XX/CHN/2019 - 2019103106 for short. ...
In this study, we determined the complete genome sequence of a CV-A19 isolate identified in a stool sample from a child with hand, foot, and …
Study of the Semileptonic Decay Λ_{c}^{+}→Λe^{+}ν_{e}.
Ablikim M, Achasov MN, Adlarson P, Albrecht M, Aliberti R, Amoroso A, An MR, An Q, Bai XH, Bai Y, Bakina O, Baldini Ferroli R, Balossino I, Ban Y, Batozskaya V, Becker D, Begzsuren K, Berger N, Bertani M, Bettoni D, Bianchi F, Bloms J, Bortone A, Boyko I, Briere RA, Brueggemann A, Cai H, Cai X, Calcaterra A, Cao GF, Cao N, Cetin SA, Chang JF, Chang WL, Chelkov G, Chen C, Chen C, Chen G, Chen HS, Chen ML, Chen SJ, Chen SM, Chen T, Chen XR, Chen XT, Chen YB, Chen ZJ, Cheng WS, Choi SK, Chu X, Cibinetto G, Cossio F, Cui JJ, Dai HL, Dai JP, Dbeyssi A, de Boer RE, Dedovich D, Deng ZY, Denig A, Denysenko I, Destefanis M, De Mori F, Ding Y, Dong J, Dong LY, Dong MY, Dong X, Du SX, Egorov P, Fan YL, Fang J, Fang SS, Fang WX, Fang Y, Farinelli R, Fava L, Feldbauer F, Felici G, Feng CQ, Feng JH, Fischer K, Fritsch M, Fritzsch C, Fu CD, Gao H, Gao YN, Gao Y, Garbolino S, Garzia I, Ge PT, Ge ZW, Geng C, Gersabeck EM, Gilman A, Goetzen K, Gong L, Gong WX, Gradl W, Greco M, Gu LM, Gu MH, Gu YT, Guan CY, Guo AQ, Guo LB, Guo RP, Guo YP, Guskov A, Han TT, Han WY, Hao XQ, Harris FA, He KK, He KL, Heinsius FH, Heinz CH, Heng YK, Herold C, Himmelreich M, Hou GY, Hou YR, Hou ZL, Hu HM, Hu JF, Hu T, Hu… See abstract for full author list ➔ Ablikim M, et al. Phys Rev Lett. 2022 Dec 2;129(23):231803. doi: 10.1103/PhysRevLett.129.231803. Phys Rev Lett. 2022. PMID: 36563214
180 results